Abbott Laboratories (ABT)
Days of sales outstanding (DSO)
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | 4.22 | 4.21 | 5.78 | 6.06 | 5.85 | 5.94 | 6.11 | 6.11 | 6.15 | 6.52 | 5.08 | 7.02 | 7.03 | 6.33 | 6.20 | 6.64 | 6.61 | 6.58 | 6.12 | 5.40 | |
| DSO | days | 86.57 | 86.63 | 63.16 | 60.25 | 62.44 | 61.43 | 59.78 | 59.74 | 59.36 | 56.00 | 71.87 | 51.99 | 51.94 | 57.69 | 58.87 | 54.97 | 55.26 | 55.46 | 59.59 | 67.65 |
September 30, 2025 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 4.22
= 86.57
Peer comparison
Sep 30, 2025
Company name
Symbol
DSO
Abbott Laboratories
ABT
86.57
CONMED Corporation
CNMD
60.93
Stryker Corporation
SYK
58.70
See also:
Abbott Laboratories Average Receivable Collection Period (Quarterly Data)